← Leaderboards
Filemon S Dela Cruz
Sloan-Kettering Inst Can Research
$1,826,092
Attributed
$3,652,183
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $749.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,652,183 · 1
By mechanism
U01$3,652,183 · 1
Top collaborators
- Andrew L Kung5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Samuel Singer$8,089,401
- Cristina R Antonescu$10,810,455
- Ping Chi$18,562,542
- Li-Xuan Qin$4,528,993
- Richard N Kolesnick$17,601,323
Others in their field
Other Emerging Leaders on “Clinically Relevant”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Bambra Strokes · Ppd Development Lp$65,000,267
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Clinically RelevantClinical TranslationAntineoplastic AgentsClinical DevelopmentAdvanced DiseaseClinical ApplicationBiological MarkersBiomarker DiscoveryAdoptionBiomedical Referral CenterBiometryBone TissueCaliforniaCancer BiologyCancer Clinical TrialCancer ModelCause Of DeathCell LineCharacteristicsChildChildhoodChildhood SarcomaChildhood Solid NeoplasmClinical Trials
Grant awards (5)
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors$727,406
U01 · FY2025 · CA
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors$730,032
U01 · FY2024 · CA
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors$730,032
U01 · FY2023 · CA
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors$715,431
U01 · FY2022 · CA
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors$749,282
U01 · FY2021 · CA